REVB CIK: 1810560

Revelation Biosciences Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.0
FY22:
−10.9
FY23:
−8.66
FY24:
−7.98
FY25:
−9.07
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.9
FY22:
−10.8
FY23:
−17.0
FY24:
−8.03
FY25:
−9.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.0
FY22:
−10.8
FY23:
−0.12
FY24:
−15.0
FY25:
−8.91
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.0
FY22:
−10.8
FY23:
−0.12
FY24:
−15.0
FY25:
−8.91

All amounts in millions USD Data sources:SEC EDGARTwelve Data